Galiano S - Search Results

1

New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.

Cirauqui N, Ceras J, Galiano S, Pérez-Silanes S, Juanenea L, Rivera G, Aldana I, Monge A. Cirauqui N, et al. Among authors: galiano s. Arzneimittelforschung. 2008;58(11):585-91. doi: 10.1055/s-0031-1296561. Arzneimittelforschung. 2008. PMID: 19137910

2

Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y(5) antagonists.

Galiano S, Erviti O, Pérez S, Moreno A, Juanenea L, Aldana I, Monge A. Galiano S, et al. Bioorg Med Chem Lett. 2004 Feb 9;14(3):597-9. doi: 10.1016/j.bmcl.2003.11.070. Bioorg Med Chem Lett. 2004. PMID: 14741250

3

Synthesis and evaluation of new arylsulfonamidomethylcyclohexyl derivatives as human neuropeptide Y Y5 receptor antagonists for the treatment of obesity.

Moreno A, Pérez S, Galiano S, Juanenea L, Erviti O, Frígola C, Aldana I, Monge A. Moreno A, et al. Among authors: galiano s. Eur J Med Chem. 2004 Jan;39(1):49-58. doi: 10.1016/j.ejmech.2003.10.001. Eur J Med Chem. 2004. PMID: 14987833

4

Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity.

Juanenea L, Galiano S, Erviti O, Moreno A, Pérez S, Aldana I, Monge A. Juanenea L, et al. Among authors: galiano s. Bioorg Med Chem. 2004 Sep 1;12(17):4717-23. doi: 10.1016/j.bmc.2004.06.023. Bioorg Med Chem. 2004. PMID: 15358298

5

Novel human neuropeptide Y Y5 receptor antagonists for the treatment of obesity. Synthesis and biological evaluation of pyridine hydrazide derivatives.

Galiano S, Erviti O, Pérez S, Moreno A, Juanenea L, Aldana I, Monge A. Galiano S, et al. Arzneimittelforschung. 2005;55(2):81-5. doi: 10.1055/s-0031-1296827. Arzneimittelforschung. 2005. PMID: 15787274

6

Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.

Galiano S, Ceras J, Cirauqui N, Pérez S, Juanenea L, Rivera G, Aldana I, Monge A. Galiano S, et al. Bioorg Med Chem. 2007 Jun 1;15(11):3896-911. doi: 10.1016/j.bmc.2007.02.049. Epub 2007 Mar 3. Bioorg Med Chem. 2007. PMID: 17407817

7

Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity.

Rivera G, Bocanegra-García V, Galiano S, Cirauqui N, Ceras J, Pérez S, Aldana I, Monge A. Rivera G, et al. Among authors: galiano s. Curr Med Chem. 2008;15(10):1025-43. doi: 10.2174/092986708784049621. Curr Med Chem. 2008. PMID: 18393860 Review.

8

Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.

Cirauqui N, Schrey AK, Galiano S, Ceras J, Pérez-Silanes S, Aldana I, Monge A, Kühne R. Cirauqui N, et al. Among authors: galiano s. Bioorg Med Chem. 2010 Nov 1;18(21):7365-79. doi: 10.1016/j.bmc.2010.09.014. Epub 2010 Sep 15. Bioorg Med Chem. 2010. PMID: 20932767

9

Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies.

Ceras J, Cirauqui N, Pérez-Silanes S, Aldana I, Monge A, Galiano S. Ceras J, et al. Among authors: galiano s. Eur J Med Chem. 2012 Jun;52:1-13. doi: 10.1016/j.ejmech.2012.02.049. Epub 2012 Mar 3. Eur J Med Chem. 2012. PMID: 22444026 Free article.

10

New 1-aryl-3-substituted propanol derivatives as antimalarial agents.

Pérez-Silanes S, Berrade L, García-Sánchez RN, Mendoza A, Galiano S, Pérez-Solórzano BM, Nogal-Ruiz JJ, Martínez-Fernández AR, Aldana I, Monge A. Pérez-Silanes S, et al. Among authors: galiano s. Molecules. 2009 Oct 14;14(10):4120-35. doi: 10.3390/molecules14104120. Molecules. 2009. PMID: 19924051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters